Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

Shoulder Innovations Clinical Data RegistryRecruiting
NCT06754150N/AUpdated Sep 10, 2026
Sponsor: Shoulder Innovations
Shoulder Arthroplasty
United States
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)Recruiting
NCT04302025Phase 2Updated Sep 10, 2026
Sponsor: Genentech, Inc.
Non-small Cell Lung Cancer
United States
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisRecruiting
NCT06408259Phase 3Updated Sep 10, 2026
Sponsor: Bristol-Myers Squibb
Multiple Sclerosis, Relapsing-Remitting
United States, Australia, Italy, Mexico, Poland +6 more
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerRecruiting
NCT05946213Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8
United States, Canada, Hong Kong, Switzerland
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisRecruiting
NCT07067463Phase 3Updated Sep 10, 2026
Sponsor: Zenas BioPharma (USA), LLC
Multiple Sclerosis (MS) Primary Progressive
United States, Bulgaria, Croatia, Czechia, Estonia +11 more
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisCompleted
NCT04436640Phase 3Updated Sep 10, 2026
Sponsor: UCB Biopharma SRL
Axial Spondyloarthritis · Ankylosing Spondylitis · r-axSpa · Nr-axSpa
United States, Belgium, Bulgaria, China, Czechia +9 more
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart DiseaseRecruiting
NCT07582848NAUpdated Sep 10, 2026
Sponsor: Carelon Research
Congenital Heart Disease (CHD)
United States
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)Recruiting
NCT07210515Phase 3Updated Sep 10, 2026
Sponsor: Ambros Therapeutics, Inc.
Complex Regional Pain Syndrome Type I
United States
Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation XchangeEnrolling By Invitation
NCT05534425NAUpdated Sep 10, 2026
Sponsor: University of California, Los Angeles
Virus Infection, RNA
United States
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerRecruiting
NCT06058377Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Negative Breast Carcinoma · Hormone Receptor-Positive Breast Carcinoma
United States, Puerto Rico
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)Recruiting
NCT05367609NAUpdated Sep 10, 2026
Sponsor: Senthil Sadhasivam
PPAP · Spine Fusion
United States
MagDI U.S. RegistryRecruiting
NCT06928545N/AUpdated Sep 10, 2026
Sponsor: GT Metabolic Solutions, Inc.
Anastomosis, Surgical · Internal Hernia · Bowel Obstruction
United States
The Impact of Dietary Salt on the Severity of EczemaRecruiting
NCT07447063Phase 4Updated Sep 10, 2026
Sponsor: University of California, San Francisco
Eczema · Atopic Dermatitis
United States
A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)Completed
NCT03694275Phase 2Updated Sep 10, 2026
Sponsor: Takeda
15q Duplication Syndrome · CDKL5 Deficiency Disease
United States
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...Recruiting
NCT05621291NAUpdated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
B-All · Acute Lymphoblastic Leukemia
United States
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid DiseasesActive Not Recruiting
NCT05552469Phase 1Updated Sep 10, 2026
Sponsor: Novartis Pharmaceuticals
Myeloid Diseases
United States, France, Germany, Hong Kong, Italy +3 more
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung TransplantationRecruiting
NCT05547698NAUpdated Sep 10, 2026
Sponsor: Mayo Clinic
Lung Transplant
United States, Belgium
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute PyelonephritisActive Not Recruiting
NCT06672978Phase 2Updated Sep 10, 2026
Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)
Acute Pyelonephritis · Complicated Urinary Tract Infection
United States, Bulgaria, Croatia, Georgia, Greece +1 more
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorRecruiting
NCT04616560Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Desmoplastic Small Round Cell Tumor · Osteosarcoma · Recurrent Desmoplastic Small Round Cell Tumor · Recurrent Kidney Wilms Tumor
United States
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell LymphomaRecruiting
NCT05272384Phase 1Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Recurrent B-Cell Non-Hodgkin Lymphoma · Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Hodgkin Lymphoma · Refractory B-Cell Non-Hodgkin Lymphoma
United States
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALSRecruiting
NCT07287397Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Vector Y Therapeutics
Amyotrophic Lateral Sclerosis
United States, Belgium, Netherlands, United Kingdom
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)Recruiting
NCT05947955Phase 2Updated Sep 10, 2026
Sponsor: BioAegis Therapeutics Inc.
Acute Respiratory Distress Syndrome · Infections
United States, Belgium, Bulgaria, Canada, Czechia +8 more
Improving Physical Ability and Cellular Senescence Elimination in HIVCompleted
NCT07144293Phase 2Updated Sep 10, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV · Frailty · Prefrail · Aging Problems
United States
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyRecruiting
NCT05987241Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Renal Pelvis Urothelial Carcinoma · Muscle Invasive Ureter Urothelial Carcinoma · Muscle Invasive Urethral Urothelial Carcinoma
United States, Canada
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic LeukemiaRecruiting
NCT03739814Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Recurrent B Acute Lymphoblastic Leukemia · Refractory B Acute Lymphoblastic Leukemia
United States, Puerto Rico

Previous page Next page